For subgroups, matching was done using the previously computed propensity scores
Even as new medicines transform treatment, approximately half of Americans with employer-sponsored insurance lack coverage for obesity management medications
GLP-1 patches are marketed as alternatives to injections, but they are not currently supported by strong clinical evidence
Iso, T., Suzuki, T., Baird, L
In order to see the results, you are looking for
This is highly speculative because: Oral bioavailability differs between species Route of administration affects systemic exposure Species differences in peptide metabolism and clearance are unknown Current Practice Patterns Current practice patterns from unregulated sources typically involve: Subcutaneous injection: 0.25-0.5 mg once or twice daily, administered near injection sites for localized effects or abdominally for systemic distribution